vs
Side-by-side financial comparison of Leslie's, Inc. (LESL) and Nutex Health, Inc. (NUTX). Click either name above to swap in a different company.
Nutex Health, Inc. is the larger business by last-quarter revenue ($151.7M vs $147.1M, roughly 1.0× Leslie's, Inc.). Nutex Health, Inc. runs the higher net margin — 7.8% vs -56.4%, a 64.2% gap on every dollar of revenue. On growth, Leslie's, Inc. posted the faster year-over-year revenue change (-16.0% vs -41.1%). Nutex Health, Inc. produced more free cash flow last quarter ($69.0M vs $-85.5M). Over the past eight quarters, Nutex Health, Inc.'s revenue compounded faster (50.0% CAGR vs -11.7%).
Leslie's, Inc., operating as Leslie's Swimming Pool Supplies, is the largest retailer of swimming pool supplies and related products. The company is headquartered in Phoenix, Arizona, and has a particularly strong retail presence in Arizona, California, Florida, Georgia and Texas.
Nutex Health Inc. is an American for-profit health care company and operator of healthcare facilities headquartered in Houston, Texas.
LESL vs NUTX — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $147.1M | $151.7M |
| Net Profit | $-83.0M | $11.8M |
| Gross Margin | 18.4% | 30.4% |
| Operating Margin | -46.7% | 20.4% |
| Net Margin | -56.4% | 7.8% |
| Revenue YoY | -16.0% | -41.1% |
| Net Profit YoY | -86.2% | -80.8% |
| EPS (diluted) | $-8.92 | $2.34 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $147.1M | — | ||
| Q4 25 | $389.2M | $151.7M | ||
| Q3 25 | — | $267.8M | ||
| Q2 25 | $500.3M | $244.0M | ||
| Q1 25 | $177.1M | $211.8M | ||
| Q4 24 | $175.2M | $257.6M | ||
| Q3 24 | $397.9M | $78.8M | ||
| Q2 24 | $569.6M | $76.1M |
| Q1 26 | $-83.0M | — | ||
| Q4 25 | $-162.8M | $11.8M | ||
| Q3 25 | — | $55.4M | ||
| Q2 25 | $21.7M | $-17.7M | ||
| Q1 25 | $-51.3M | $21.2M | ||
| Q4 24 | $-44.6M | $61.6M | ||
| Q3 24 | $-9.9M | $-8.8M | ||
| Q2 24 | $60.6M | $-364.0K |
| Q1 26 | 18.4% | — | ||
| Q4 25 | 38.6% | 30.4% | ||
| Q3 25 | — | 57.8% | ||
| Q2 25 | 39.6% | 51.2% | ||
| Q1 25 | 24.8% | 55.9% | ||
| Q4 24 | 27.2% | 55.0% | ||
| Q3 24 | 36.0% | 27.8% | ||
| Q2 24 | 40.2% | 29.7% |
| Q1 26 | -46.7% | — | ||
| Q4 25 | -38.6% | 20.4% | ||
| Q3 25 | — | 48.7% | ||
| Q2 25 | 13.7% | 13.8% | ||
| Q1 25 | -27.3% | 38.1% | ||
| Q4 24 | -22.7% | 44.4% | ||
| Q3 24 | 6.6% | 12.3% | ||
| Q2 24 | 17.2% | 7.0% |
| Q1 26 | -56.4% | — | ||
| Q4 25 | -41.8% | 7.8% | ||
| Q3 25 | — | 20.7% | ||
| Q2 25 | 4.3% | -7.3% | ||
| Q1 25 | -29.0% | 10.0% | ||
| Q4 24 | -25.4% | 23.9% | ||
| Q3 24 | -2.5% | -11.2% | ||
| Q2 24 | 10.6% | -0.5% |
| Q1 26 | $-8.92 | — | ||
| Q4 25 | $-20.59 | $2.34 | ||
| Q3 25 | — | $7.76 | ||
| Q2 25 | $0.12 | $-2.95 | ||
| Q1 25 | $-0.28 | $3.33 | ||
| Q4 24 | $-4.82 | $11.56 | ||
| Q3 24 | $-2.46 | $-1.72 | ||
| Q2 24 | $0.33 | $-0.07 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $3.6M | $185.6M |
| Total DebtLower is stronger | $781.6M | — |
| Stockholders' EquityBook value | $-489.9M | $329.4M |
| Total Assets | $649.4M | $918.5M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $3.6M | — | ||
| Q4 25 | $64.3M | $185.6M | ||
| Q3 25 | — | $166.0M | ||
| Q2 25 | $42.7M | $96.7M | ||
| Q1 25 | $17.3M | $84.7M | ||
| Q4 24 | $11.6M | $40.6M | ||
| Q3 24 | $108.5M | $46.9M | ||
| Q2 24 | $74.4M | $40.8M |
| Q1 26 | $781.6M | — | ||
| Q4 25 | $756.6M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $776.6M | — | ||
| Q1 25 | $858.1M | — | ||
| Q4 24 | $796.6M | — | ||
| Q3 24 | $783.7M | — | ||
| Q2 24 | $783.7M | — |
| Q1 26 | $-489.9M | — | ||
| Q4 25 | $-408.0M | $329.4M | ||
| Q3 25 | — | $317.2M | ||
| Q2 25 | $-246.2M | $235.3M | ||
| Q1 25 | $-269.5M | $176.9M | ||
| Q4 24 | $-220.0M | $132.4M | ||
| Q3 24 | $-177.1M | $60.4M | ||
| Q2 24 | $-168.2M | $62.7M |
| Q1 26 | $649.4M | — | ||
| Q4 25 | $741.5M | $918.5M | ||
| Q3 25 | — | $964.5M | ||
| Q2 25 | $989.5M | $841.0M | ||
| Q1 25 | $1.0B | $761.9M | ||
| Q4 24 | $967.0M | $655.3M | ||
| Q3 24 | $1.1B | $438.5M | ||
| Q2 24 | $1.1B | $422.4M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-81.1M | $70.4M |
| Free Cash FlowOCF − Capex | $-85.5M | $69.0M |
| FCF MarginFCF / Revenue | -58.1% | 45.5% |
| Capex IntensityCapex / Revenue | 2.9% | 0.9% |
| Cash ConversionOCF / Net Profit | — | 5.95× |
| TTM Free Cash FlowTrailing 4 quarters | $7.6M | $245.6M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $-81.1M | — | ||
| Q4 25 | $48.2M | $70.4M | ||
| Q3 25 | — | $99.5M | ||
| Q2 25 | $114.9M | $27.3M | ||
| Q1 25 | $-49.2M | $51.0M | ||
| Q4 24 | $-105.1M | $54.0K | ||
| Q3 24 | $47.1M | $6.8M | ||
| Q2 24 | $175.5M | $13.3M |
| Q1 26 | $-85.5M | — | ||
| Q4 25 | $41.8M | $69.0M | ||
| Q3 25 | — | $99.2M | ||
| Q2 25 | $107.1M | $26.5M | ||
| Q1 25 | $-55.8M | $50.9M | ||
| Q4 24 | $-109.8M | $-341.0K | ||
| Q3 24 | $34.1M | $6.2M | ||
| Q2 24 | $165.2M | $12.7M |
| Q1 26 | -58.1% | — | ||
| Q4 25 | 10.7% | 45.5% | ||
| Q3 25 | — | 37.0% | ||
| Q2 25 | 21.4% | 10.9% | ||
| Q1 25 | -31.5% | 24.0% | ||
| Q4 24 | -62.6% | -0.1% | ||
| Q3 24 | 8.6% | 7.8% | ||
| Q2 24 | 29.0% | 16.7% |
| Q1 26 | 2.9% | — | ||
| Q4 25 | 1.7% | 0.9% | ||
| Q3 25 | — | 0.1% | ||
| Q2 25 | 1.6% | 0.3% | ||
| Q1 25 | 3.7% | 0.0% | ||
| Q4 24 | 2.7% | 0.2% | ||
| Q3 24 | 3.2% | 0.8% | ||
| Q2 24 | 1.8% | 0.7% |
| Q1 26 | — | — | ||
| Q4 25 | — | 5.95× | ||
| Q3 25 | — | 1.80× | ||
| Q2 25 | 5.29× | — | ||
| Q1 25 | — | 2.40× | ||
| Q4 24 | — | 0.00× | ||
| Q3 24 | — | — | ||
| Q2 24 | 2.89× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
LESL
Segment breakdown not available.
NUTX
| Hospital Division | $143.7M | 95% |
| Population Health Management Division | $8.0M | 5% |
